EpiCore-A Common Data Model for Pharmacoepidemiological Studies in Denmark, Norway, and Sweden.
Gespeichert in:
| Titel: | EpiCore-A Common Data Model for Pharmacoepidemiological Studies in Denmark, Norway, and Sweden. |
|---|---|
| Autoren: | Jensen PB; Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark., Andersen JH; Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark., Ernst MT; Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark., Olesen M; Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark., Karlstad Ø; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway., Furu K; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway., Eriksson J; Center for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Gembert K; Center for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Pottegård A; Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark. |
| Quelle: | Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2025 Nov; Vol. 34 (11), pp. e70241. |
| Publikationsart: | Journal Article |
| Sprache: | English |
| Info zur Zeitschrift: | Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Chichester, West Sussex : Wiley, 1992- |
| MeSH-Schlagworte: | Pharmacoepidemiology*/methods , Common Data Elements*, Humans ; Norway/epidemiology ; Sweden/epidemiology ; Denmark ; Databases, Factual |
| Abstract: | Purpose: The use of common data models (CDMs) is increasing; however, the complexity of many CDM frameworks constitutes a barrier for their use. For many local and collaborative use cases, simpler CDMs can suffice. Here, we propose the EpiCore CDM, a simple CDM framework for use in Scandinavian pharmacoepidemiological studies. Methods: The EpiCore CDM was developed based on a set of guiding principles. It should (i) accommodate the most common elements of typical data sources in the field and region, (ii) be accessible to users without needing advanced technical expertise or database infrastructure, (iii) prioritize structural and syntactic harmonization of data and defer clinical concept mapping to the analytical phase, (iv) be usable in both collaborative and single site settings, and (v) include support for quality control procedures. Results: The EpiCore CDM comprises two mandatory administrative tables (person and observation), six optional event tables (diagnosis, procedure, encounter, drug, primcare, and cancer) and three optional lookup tables (drug_info, organisation_info, and prescriber_info). Each table, along with its columns and constraints is specified according to an EpiCore CDM specification template. This provides easy documentation and integrates with an R-package called EpiCoreAssistant, which provides quality control tools for testing the compliance of a CDM instance with the EpiCore specification. In the event that a project requires customization of the CDM, this is easily implemented in the template and testing. A step-by-step description is presented, demonstrating the steps involved in a typical CDM-based collaborative pharmacoepidemiological study using the EpiCore CDM. Conclusions: We present the EpiCore CDM, a specification template and an R package that offers a simple framework for improved workflows, standardizations and collaboration, focused on Scandinavian pharmacoepidemiological studies and with relevance for a broad palette of register-based health care researchers. (© 2025 John Wiley & Sons Ltd.) |
| References: | K. Laugesen, J. F. Ludvigsson, M. Schmidt, et al., “Nordic Health Registry‐Based Research: A Review of Health Care Systems and Key Registries,” Clinical Epidemiology 13 (2021): 533–554, https://doi.org/10.2147/CLEP.S314959. H. Kieler, M. Artama, A. Engeland, et al., “Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Persistent Pulmonary Hypertension in the Newborn: Population Based Cohort Study From the Five Nordic Countries,” BMJ (Clinical Research Ed.) 344 (2011): d8012, https://doi.org/10.1136/bmj.d8012. S. M. Baxter, L. C. Lund, J. H. Andersen, et al., “Glucagon‐Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study,” Thyroid 35, no. 1 (2025): 69–78, https://doi.org/10.1089/thy.2024.0387. A. Pottegård, L. C. Lund, Ø. Karlstad, et al., “Arterial Events, Venous Thromboembolism, Thrombocytopenia, and Bleeding After Vaccination With Oxford‐AstraZeneca ChAdOx1‐S in Denmark and Norway: Population Based Cohort Study,” BMJ (Clinical Research Ed.) 373 (2021): n1114, https://doi.org/10.1136/bmj.n1114. E. Simonsen, L. C. Lund, M. T. Ernst, et al., “Use of Semaglutide and Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy: A Danish–Norwegian Cohort Study,” preprint, December 11, 2024, https://doi.org/10.1101/2024.12.09.24318574. R. Wesselhoeft, P. B. Jensen, A. Talati, et al., “Trends in Antidepressant Use Among Children and Adolescents: A Scandinavian Drug Utilization Study,” Acta Psychiatrica Scandinavica 141, no. 1 (2020): 34–42, https://doi.org/10.1111/acps.13116. S. R. Raman, K. K. C. Man, S. Bahmanyar, et al., “Trends in Attention‐Deficit Hyperactivity Disorder Medication Use: A Retrospective Observational Study Using Population‐Based Databases,” Lancet Psychiatry 5, no. 10 (2018): 824–835, https://doi.org/10.1016/S2215‐0366(18)30293‐1. R. Gini, M. C. J. Sturkenboom, J. Sultana, et al., “Different Strategies to Execute Multi‐Database Studies for Medicines Surveillance in Real‐World Setting: A Reflection on the European Model,” Clinical Pharmacology & Therapeutics 108, no. 2 (2020): 228–235, https://doi.org/10.1002/cpt.1833. The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), “Guide on Methodological Standards in Pharmacoepidemiology (Revision 11). EMA/95098/2010,” http://www.encepp.eu/standards_and_guidance. S. J. Reisinger, P. B. Ryan, D. J. O'Hara, et al., “Development and Evaluation of a Common Data Model Enabling Active Drug Safety Surveillance Using Disparate Healthcare Databases,” Journal of the American Medical Informatics Association 17, no. 6 (2010): 652–662, https://doi.org/10.1136/jamia.2009.002477. R. J. Desai, K. Marsolo, J. Smith, et al., “The FDA Sentinel Real World Evidence Data Enterprise (RWE‐DE),” Pharmacoepidemiology and Drug 33, no. 10 (2024): e70028, https://doi.org/10.1002/pds.70028. N. H. Thurin, R. Pajouheshnia, G. Roberto, et al., “From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding,” Clinical Pharmacology and Therapeutics 111, no. 1 (2022): 321–331, https://doi.org/10.1002/cpt.2476. P. B. Jensen, “Epicoreassistant. Epicoreassistant Gitlab Repository,” 2025, https://gitlab.sdu.dk/pharmacoepi/epicoreassistant. S. V. Wang, A. Pottegård, W. Crown, et al., “HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real‐World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force,” Value in Health 25, no. 10 (2022): 1663–1672, https://doi.org/10.1016/j.jval.2022.09.001. M. Klik, “fst: Lightning Fast Serialization of Data Frames,” 2022, http://www.fstpackage.org. J. M. Cohen, C. E. Cesta, L. Kjerpeseth, et al., “A Common Data Model for Harmonization in the Nordic Pregnancy Drug Safety Studies (NorPreSS),” Norsk Epidemiologi 29, no. 1–2 (2021): 117–123. M. G. Kahn, T. J. Callahan, J. Barnard, et al., “A Harmonized Data Quality Assessment Terminology and Framework for the Secondary Use of Electronic Health Record Data,” eGEMs (Generating Evidence & Methods to Improve Patient Outcomes) 4, no. 1 (2016): 18, https://doi.org/10.13063/2327‐9214.1244. “Apache Parquet,” https://parquet.apache.org/docs/. European Medicines Agency (EMA), “Data Analysis and Real World Interrogation Network (DARWIN EU),” accessed August 21, 2024, https://www.ema.europa.eu/en/about‐us/how‐we‐work/big‐data/real‐world‐evidence/data‐analysis‐real‐world‐interrogation‐network‐darwin‐eu. |
| Contributed Indexing: | Keywords: CDM; pharmacoepidemiology; research infrastructure |
| Entry Date(s): | Date Created: 20251104 Date Completed: 20251104 Latest Revision: 20251104 |
| Update Code: | 20251104 |
| DOI: | 10.1002/pds.70241 |
| PMID: | 41185087 |
| Datenbank: | MEDLINE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstract: | Purpose: The use of common data models (CDMs) is increasing; however, the complexity of many CDM frameworks constitutes a barrier for their use. For many local and collaborative use cases, simpler CDMs can suffice. Here, we propose the EpiCore CDM, a simple CDM framework for use in Scandinavian pharmacoepidemiological studies.<br />Methods: The EpiCore CDM was developed based on a set of guiding principles. It should (i) accommodate the most common elements of typical data sources in the field and region, (ii) be accessible to users without needing advanced technical expertise or database infrastructure, (iii) prioritize structural and syntactic harmonization of data and defer clinical concept mapping to the analytical phase, (iv) be usable in both collaborative and single site settings, and (v) include support for quality control procedures.<br />Results: The EpiCore CDM comprises two mandatory administrative tables (person and observation), six optional event tables (diagnosis, procedure, encounter, drug, primcare, and cancer) and three optional lookup tables (drug_info, organisation_info, and prescriber_info). Each table, along with its columns and constraints is specified according to an EpiCore CDM specification template. This provides easy documentation and integrates with an R-package called EpiCoreAssistant, which provides quality control tools for testing the compliance of a CDM instance with the EpiCore specification. In the event that a project requires customization of the CDM, this is easily implemented in the template and testing. A step-by-step description is presented, demonstrating the steps involved in a typical CDM-based collaborative pharmacoepidemiological study using the EpiCore CDM.<br />Conclusions: We present the EpiCore CDM, a specification template and an R package that offers a simple framework for improved workflows, standardizations and collaboration, focused on Scandinavian pharmacoepidemiological studies and with relevance for a broad palette of register-based health care researchers.<br /> (© 2025 John Wiley & Sons Ltd.) |
|---|---|
| ISSN: | 1099-1557 |
| DOI: | 10.1002/pds.70241 |